671
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Targets and assay types for COVID-19 diagnosis

, , &

References

  • Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet. 2020, 395(10223), 497e506.
  • Wu, J. T.; Leung, K.; Leung, G. M. Nowcasting and Forecasting the Potential Domestic and International Spread of the SARS-CoV-2 Outbreak Originating in Wuhan, China: A Modelling Study. Lancet. 2020, 395, 689e97. DOI: 10.1016/S0140-6736(20)30260-9.
  • Ecdc.europa.eu. Covid-19: an overview. Dataset Collected 6: 00-10:00CET[about 2 Screens]. 2020. https://www.ecdc.europa.eu/en/novelcoronavirus-china
  • Wölfel, R.; Corman, V. M.; Guggemos, W.; Seilmaier, M.; Zange, S.; Müller, M. A.; Niemeyer, D.; Jones, T. C.; Vollmar, P.; Rothe, C.;, et al. Virological Assessment of Hospitalized Patients with COVID-2019. Nature. 2020 April 1, 581(7809), 465–469. DOI: 10.1038/s41586-020-2196-x.
  • Yang, Y.; Yang, M.; Shen, C.; Wang, F.; Yuan, J.; Li, J.; et al. Evaluating the Accuracy of Different Respiratory Specimens in the Laboratory Diagnosis and Monitoring the Viral Shedding of 2019-nCoV Infections. medRxiv. 2020. 2020.02.11.20021493.
  • Czumbel, L. M.; Kiss, S.; Farkas, N.; Mandel, I.; Hegyi, A. E.; Nagy, A. K.; et al. Saliva as A Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis. medRxiv. 2020. 2020.05.26.20112565.
  • Zou, L.; Ruan, F.; Huang, M.; Liang, L.; Huang, H.; Hong, Z.; Yu, J.; Kang, M.; Song, Y.; Xia, J.; et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N. Engl. J. Med. 2020, 382(12), 1177–1179.
  • Aguilar, J. B.; Faust, J. S.; Westafer, L. M.; Gutierrez, J. B.; Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission. medRxiv. 2020. 2020.03.18.20037994.
  • Huang, L.-S.; Li, L.; Dunn, L.; He, M. Taking Account of Asymptomatic Infections in Modeling the Transmission Potential of the COVID-19 Outbreak on the Diamond Princess Cruise Ship. medRxiv. 2020. 2020.04.22.20074286
  • Wei, W. E.; Li, Z.; Chiew, C. J.; Yong, S. E.; Toh, M. P. Presymptomatic Transmission of SARS-CoV-2 — Singapore. MMWR Morb. Mortal. Wkly. Rep. 2020. January 23–March 16, 2020. ePub: 1 April 2020. DOI: 10.15585/mmwr.mm6914e1.
  • Backer, J. A.; Klinkenberg, D.; Wallinga, J. Incubation Period of 2019 Novel Coronavirus (2019-ncov) Infections among Travellers from Wuhan, China, 20–28 January 2020. Eurosurveillance. 2020, 25(5). DOI: 10.2807/1560-7917.ES.2020.25.5.2000062.
  • Kim, D.; Quinn, J.; Pinsky, B.; Shah, N. H.; Brown, I. Rates of Co-infection between SARSCoV-2 and Other Respiratory Pathogens. JAMA. 2020, 323, 2085–2086. DOI: 10.1001/jama.2020.6266.
  • Ackermann, M.; Verleden, S. E.; Kuehnel, M.; Haverich, A.; Welte, T.; Laenger, F.; Vanstapel, A.; Werlein, C.; Stark, H.; Tzankov, A.; et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N. Engl. J. Med. 2020, 383(2), 120–128.
  • Boni, M. F.; Lemey, P.; Jiang, X.; Lam, T. T.-Y.; Perry, B. W.; Castoe, T. A.; Rambaut, A.; Robertson, D. L. Evolutionary Origins of the SARS-CoV-2 Sarbecovirus Lineage Responsible for the COVID-19 Pandemic. Nat. Microbiol. 2020, 5(11), 1408–1417.
  • Zhang, Y.-Z.; Holmes, E. C.; Genomic, A. Perspective on the Origin and Emergence of SARSCoV-2. Cell. 2020, 181(2), 223–227. DOI: 10.1016/j.cell.2020.03.035.
  • Liu, W.; Liu, L.; Kou, G.; Zheng, Y.; Ding, Y.; Ni, W.; Wang, Q.; Tan, L.; Wu, W.; Tang, S.; et al. Evaluation of Nucleocapsid and Spike Protein-based Enzyme Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2. J. Clin. Microbiol. 2020 June, 58(6), e00461–20. DOI: 10.1128/JCM.00461-20.
  • Xiaofeng, D.; Zhang, X.; Ostrikov, K.; Abrahamyan, L. Host Receptors: The Key to Establishing Cells with Broad Viral Tropism for Vaccine Production. Crit. Rev. Microbiol. 2020, 46(2), 147–168. DOI: 10.1080/1040841X.2020.1735992.
  • Pan, Y.; Zhang, D.; Yang, P.; Poon, L. L. M.; Wang, Q. Viral Load of SARS-CoV-2 in Clinical Samples. Lancet Infect Dis. 2020, 20(4), 411–412. DOI: 10.1016/S1473-3099(20)30113-4.
  • Shereen, M. A.; Khan, S.; Kazmi, A.; Bashir, N.; Siddique, R. COVID-19 Infection: Origin, Transmission, and Characteristics of Human Coronaviruses. J. Adv. Res. 2020, 24, 91–98. DOI: 10.1016/j.jare.2020.03.005.
  • Corman, V. M.; Landt, O.; Kaiser, M.; Molenkamp, R.; Meijer, A.; Chu, D. K. W.; Bleicker, T.; Brünink, S.; Schneider, J.; Schmidt, M. L.; et al. Detection of 2019 Novel Coronavirus (2019-ncov) by Real-time RT-PCR. Eurosurveillance. 2020, 25, 2000045. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045.
  • Vashist, S. K. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends. Diagnostics. 2020, 10, 202. DOI: 10.3390/diagnostics10040202.
  • European Commission (EC). Current Performance of COVID-19 Test Methods and Devices and Proposed Performance Criteria. Brussels: EC; 2020 April, 16. https://ec.europa.eu/docsroom/documents/40805 (accessed April 21).
  • COVID-19 in Vitro Diagnostic Devices and Test Methods Database: European Commission. 2020. https://covid-19-diagnostics.jrc.ec.europa.eu/.
  • FIND. SARS-COV-2 Molecular Assay Evaluation: Results. 2020, April 22. https://www.finddx.org/covid-19/sarscov2-eval-molecular/molecular-eval-results/.
  • COMMISSION DIRECTIVE (EU) 2020/739 of 3 June 2020 Amending Annex III to DIRECTIVE 2000/54/EC of the European Parliament and of the Council as Regards the Inclusion of SARS-CoV-2 in the List of Biological Agents Known to Infect Humans and Amending COMMISSION DIRECTIVE (EU) 2019/1833. 2020.
  • European Commission (EC). Communication from the Commission: Guidelines on COVID-19 in Vitro Diagnostic Tests and Their Performance. Brussels, 15.4.2020 C(2020) 2391 Final. Brussels: EC. https://ec.europa.eu/info/sites/info/files/testing_kits_communication.pdf. ( accesed April 21, 2020).
  • Diagnostic Detection of Wuhan Coronavirus 2019 by Real-Time RT-PCR. https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf ( accessed on June 13, 2020).
  • COVID-19 Diagnostics Resource Centre. https://www.finddx.org/covid-19/ ( accessed June 13, 2020).
  • Deepak, S. A.; Kottapalli, K. R.; Rakwal, R.; Oros, G.; Rangappa, K. S.; Iwahashi, H.; Masuo, Y.; Agrawal, G. K. Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes. Curr. Genom. 2007, 8, 234–251. DOI: 10.2174/138920207781386960.
  • Rapid Test for COVID-19 (SARS-CoV-2). https://www.bosch-vivalytic.com/en/product/vivalytic-tests/vri-multiplex-test/ ( accessed May, 9 2020).
  • SARS-CoV-2 Real Time PCR LAB-KIT™. https://www.biomaxima.com/736-koronawirussars-cov-2.html ( accessed April 28, 2020).
  • Huang, W. E.; Lim, B.; Hsu, C. C.; Xiong, D.; Wu, W.; Yu, Y.; Jia, H.; Wang, Y.; Zeng, Y.; Ji, M.; et al. RT-LAMP for Rapid Diagnosis of Coronavirus SARS-CoV-2. Microb. Biotechnol. 2020, 13, 950–961. DOI: 10.1111/1751-7915.13586.
  • Cui, Z.; Chang, H.; Wang, H.; Lim, B.; Hsu, C. C.; Yu, Y.; Jia, H.; Wang, Y.; Zeng, Y.; Ji, M.; et al. Development of a Rapid Test Kit for SARS-CoV-2: An Example of Product Design. Biodes. Manuf. 2020, 1–4. DOI: 10.1007/s42242-020-00075-7.
  • Moran, A.; Beavis, K. G.; Matushek, S. M.; Ciaglia, C.; Francois, N.; Tesic, V.; Love, N. The Detection of SARS-CoV-2 Using the Cepheid Xpert Xpress SARS-CoV-2 and Roche Cobas SARS-CoV-2 Assays. J. Clin. Microbiol. 2020. DOI: 10.1128/JCM.00772-20.
  • Watson, J.; Whiting, P. F.; Brush, J. E. Interpreting a Covid-19 Test Result. BMJ. 2020, 369, m1808. [PubMed]. DOI: 10.1136/bmj.m1808.
  • Neagu, M. The Bumpy Road to Achieve Herd Immunity in COVID-19. J. Immunoassay Immunochem. 2020. DOI: 10.1080/15321819.2020.1833919.
  • Constantin, C.; Neagu, M.; Supeanu, T.; Chiurciu, V.; Spandidos, D. IgY-turning the Page toward Passive Immunization in COVID-19 Infection. Exp. Ther. Med. 2020 May, 20, 151–158. DOI: 10.3892/etm.2020.8704.
  • To, K. K.; Tsang, O. T.; Leung, W. S.; Tam, A. R.; Wu, T.-C.; Lung, D. C.; Yip, C. C.-Y.; Cai, J.-P.; Chan, J. M.-C.; Chik, T. S.-H.; et al. Temporal Profiles of Viral Load in Posterior Oropharyngeal Saliva Samples and Serum Antibody Responses during Infection by SARS-CoV-2: An Observational Cohort Study. Lancet Infect. Dis. 2020, 20, 565–574. DOI: 10.1016/S1473-3099(20)30196-1.
  • Jin, Y.; Wang, M. ;.; Zuo, Z.; Fan, C.; Ye, F.; Cai, Z.; Wang, Y.; Cui, H.; Pan, K.; Xu, A.; et al. Diagnostic Value and Dynamic Variance of Serum Antibody in Coronavirus Disease 2019. Int. J. Infect. Dis. 2020, 94, 49–52. DOI: 10.1016/j.ijid.2020.03.065.
  • Zheng, S.; Fan, J.; Yu, F.; Feng, B.; Lou, B.; Zou, Q.; Xie, G.; Lin, S.; Wang, R.; Yang, X.; et al. Viral Load Dynamics and Disease Severity in Patients Infected with SARS-CoV-2 in Zhejiang Province, China, January–March 2020: Retrospective Cohort Study. BMJ. 2020, 369, m1443. DOI: 10.1136/bmj.m1443.
  • Health Information and Quality Authority, Ireland. Evidence Summary for COVID-19 Viral Load over Course of Infection. 2020. https://www.hiqa.ie/sites/default/files/2020-04/Evidence-Summary_COVID-19_duration-of-infectivity-viral-load.pdf (accessed April 29, 2020).
  • Zhao, J.; Yuan, Q.; Wang, H.; et al. Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019. Clin. Infect. Dis. 2020. published online March 28. DOI: 10.1093/cid/ciaa344.
  • Lou, B.; Li, T.; Zheng, S.; Su, -Y.-Y.; Li, Z.-Y.; Liu, W.; Yu, F.; Ge, S.-X.; Zou, Q.-D.; Yuan, Q.; et al. Serology Characteristics of SARS-CoV-2 Infection since Exposure and Post Symptoms Onset. Eur. Respir. J. 2020. published online May 19. DOI: 10.1183/13993003.00763-2020.
  • Guo, L.; Ren, L.; Yang, S.; Xiao, M.; Chang, D.; Yang, F.; Dela Cruz, C. S.; Wang, Y.; Wu, C.; Xiao, Y.; et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin. Infect. Dis. 2020, 71, 778–785. published online March 21. DOI: 10.1093/cid/ciaa310.
  • Tan, W.; Lu, Y. ;.; Zhang, J.; et al. Viral Kinetics and Antibody Responses in Patients with COVID-19. medRxiv 2020. published online March 26. (preprint). DOI: 10.1101/2020.03.24.20042382.
  • Long, Q.-X.; Liu, B.-Z.; Deng, H.-J.; Wu, G.-C.; Deng, K.; Chen, Y.-K.; Liao, P.; Qiu, J.-F.; Lin, Y.; Cai, X.-F.; et al. Antibody Responses to SARS-CoV-2 in Patients with COVID-19. Nat. Med. 2020, 26, 845–848. DOI: 10.1038/s41591-020-0897-1.
  • Ni, L.; Ye, F.; Cheng, M.-L.; Feng, Y.; Deng, Y.-Q.; Zhao, H.; Wei, P.; Ge, J.; Gou, M.; Li, X.; et al. Detection of SARS-CoV-2-specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity. 2020, 52, 971–7.e3. DOI: 10.1016/j.immuni.2020.04.023.
  • Sun, B.; Feng, Y.; Mo, X.; Zheng, P.; Wang, Q.; Li, P.; Peng, P.; Liu, X.; Chen, Z.; Huang, H.; et al. Kinetics of SARS-CoV-2 Specific IgM and IgG Responses in COVID-19 Patients. Emerg. Microbes. Infect. 2020, 9, 940–948. DOI: 10.1080/22221751.2020.1762515.
  • Wang, Z.; Li, H.; Li, J.; et al. Elevated Serum IgM Levels Indicate Poor Outcome in Patients with Coronavirus Disease 2019 Pneumonia: A Retrospective Case-control Study. medRxiv, 2020. published online March 27. (preprint), DOI: 10.1101/2020.03.22.20041285.
  • De Walque, D. B. C. M.; Friedman, J.; Gatti, R. V.; Mattoo, A. How Two Tests Can Help Contain COVID-19 and Revive the Economy. April 8, 2020. https://openknowledge.worldbank.org/bitstream/handle/10986/33583/How-Two-Tests-Can-Help-Contain-COVID-19-and-Revive-the-Economy.pdf?sequence=1&isAllowed=y (accessed April 29, 2020).
  • Jiang, S.; Hillyer, C.; Du, L. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. Trends Immunol. 2020, 41, 355–359. DOI: 10.1016/j.it.2020.03.007.
  • Wu, Y.; Wang, F.; Shen, C.; Peng, W.; Li, D.; Zhao, C.; Li, Z.; Li, S.; Bi, Y.; Yang, Y.; et al. A Noncompeting Pair of Human Neutralizing Antibodies Block COVID-19 Virus Binding to Its Receptor ACE2. Science. 2020, 368, 1274–1278. DOI: 10.1126/science.abc2241.
  • Ju, B.; Zhang, Q.; Ge, J.; Wang, R.; Sun, J.; Ge, X.; Yu, J.; Shan, S.; Zhou, B.; Song, S.; et al. Human Neutralizing Antibodies Elicited by SARSCoV-2 Infection. Nature. 2020 May 26, 584, 115–119. [Epub ahead of print]. DOI: 10.1038/s41586-020-2380-z.
  • Padoan, A.; Cosma, C.; Sciacovelli, L.; Faggian, D.; Plebani, M. Analytical Performances of a Chemiluminescence Immunoassay for SARS‐CoV‐2 IgM/IgG and Antibody Kinetics. Clin. Chem. Lab. Med. 2020, 58, 1081‐ 1088. DOI: 10.1515/cclm-2020-0443.
  • Lippi, G.; Salvagno, G. L.; Pegoraro, M.; Militello, V.; Caloi, C.; Peretti, A.; Gaino, S.; Bassi, A.; Bovo, C.; Lo Cascio, G. Assessment of Immune Response to SARS‐CoV‐2 with Fully Automated MAGLUMI 2019‐nCoV IgG and IgM Chemiluminescence Immunoassays. Clin. Chem. Lab. Med. 2020, 58, 1156‐ 1159. DOI: 10.1515/cclm-2020-0473.
  • Montesinos, I.; Gruson, D.; Kabamba, B.; Dahma, H.; Van den Wijngaert, S.; Reza, S.; Carbone, V.; Vandenberg, O.; Gulbis, B.; Wolff, F.; et al. Evaluation of Two Automated and Three Rapid Lateral Flow Immunoassays for the Detection of anti‐SARS‐CoV‐2 Antibodies. J. Clin. Virol. 2020, 128, 104413. DOI: 10.1016/j.jcv.2020.104413.
  • Koczula, K. M.; Gallotta, A. Lateral Flow Assays. Essays Biochem. 2016, 60, 111–120. DOI: 10.1042/EBC20150012.
  • Kubina, R.; Dziedzic, A. Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics. Diagnostics. 2020, 10, 434. DOI: 10.3390/diagnostics10060434.
  • Hall, D. A.; Ptacek, J.; Snyder, M. Protein Microarray Technology. Mech. Ageing. Dev. 2007, 128, 161–167. DOI: 10.1016/j.mad.2006.11.021.
  • Molecular and Antibody Point-Of-Care Tests to Support the Screening, Diagnosis and Monitoring of COVID-19. https://www.cebm.net/covid-19/molecular-and-antibody-point-of-care-teststo-support-the-screening-diagnosis-and-monitoring-of-covid-19/ ( accessed June, 13 2020).
  • Zhou, B.; She, J.; Wang, Y.; Ma, X. The Duration of Viral Shedding of Discharged Patients with Severe COVID-19. Clin. Infect. Dis. 2020 Apr 17. [Epub ahead of print]. DOI: 10.1093/cid/ciaa451.
  • Zhang, G.; Nie, S.; Zhang, Z.; et al. Longitudinal Change of SARS-CoV2 Antibodies in Patients with COVID-19. J. Infect. Dis. 2020 May 2. [Epub ahead of print]. DOI: 10.1093/infdis/jiaa229.
  • Gurbuz, M. Molecular and Serological Tests for COVID-19. Eur. J. Pulmonol. 2020, 22, S29–34. DOI: 10.4103/ejop.ejop_43_20.
  • Li, Z.; Yi, Y.; Luo, X.; Xiong, N.; Liu, Y.; Li, S.; et al. Development and Clinical Application of a Rapid IgM IgG Combined Antibody Test for SARS CoV 2 Infection Diagnosis. J. Med. Virol. 2020.
  • Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; et al. Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. Lancet. 2020, 395, 565–74. DOI: 10.1016/S0140-6736(20)30251-8.
  • Traugott, M.; Aberle, S. W.; Aberle, J. H.; Griebler, H.; Karolyi, M.; Pawelka, E.; Puchhammer-Stöckl, E.; Zoufaly, A.; Weseslindtner, L. Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests. J. Infect. Dis. Jul 2020, 222(3), 362–366. DOI: 10.1093/infdis/jiaa305.
  • Okba, N. M. A.; Muller, M. A.; Li, W.; Wang, C.; GeurtsvanKessel, C. H.; Corman, V. M.; Lamers, M. M.; Sikkema, R. S.; de Bruin, E.; Chandler, F. D.; et al. Severe Acute Respiratory Syndrome Coronavirus 2-specific Antibody Responses in Coronavirus Disease 2019 Patients. Emerg. Infect. Dis. 2020, 26. DOI: 10.3201/eid2607.200841.
  • Petherick, A. Developing Antibody Tests for SARS–CoV–2. Lancet. 2020, 395, 1101–2. DOI: 10.1016/S0140-6736(20)30788-1.
  • Beavis, K. G.; Matushek, S. M.; Abeleda, A.; Bethel, C.; Hunt, C.; Gillen, S.; Moran, A.; Tesic, V. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for Detection of IgA and IgG Antibodies. J. Clin.l Virol. 2020, 129, 104468. DOI: 10.1016/j.jcv.2020.104468.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.